Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

BOSTON SCIENTIFIC CORPORATION

(BSX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
03/23/2020 03/24/2020 03/25/2020 03/26/2020 03/27/2020 Date
25.83(c) 28.22(c) 29.92(c) 31.42(c) 30.61(c) Last
17 190 915 16 752 770 19 681 678 13 137 524 10 990 638 Volume
-5.18% +9.25% +6.02% +5.01% -2.58% Change
More quotes
Financials (USD)
Sales 2020 11 605 M
EBIT 2020 2 952 M
Net income 2020 1 469 M
Debt 2020 6 630 M
Yield 2020 -
Sales 2021 12 743 M
EBIT 2021 3 416 M
Net income 2021 1 925 M
Debt 2021 4 604 M
Yield 2021 -
P/E ratio 2020 29,8x
P/E ratio 2021 22,9x
EV / Sales2020 4,26x
EV / Sales2021 3,72x
Capitalization 42 830 M
More Financials
Company
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (61.1%): products used in cardiology surgeries (42.9% of net sales), cardiac rhythm management (29.6%),... 
More about the company
Surperformance© ratings of Boston Scientific Corporat
Trading Rating : Investor Rating :
More Ratings
Latest news on BOSTON SCIENTIFIC CORPORAT
03/09BOSTON SCIENTIFIC : Making it Work for Working Parents
PU
03/05BOSTON SCIENTIFIC : Description Statement of Changes in Beneficial Ownership
PU
03/04BOSTON SCIENTIFIC : Women with transvaginal mesh implants to share $21.5 million..
AQ
03/03BOSTON SCIENTIFIC : Description Statement of Changes in Beneficial Ownership
PU
02/28BOSTON SCIENTIFIC : Medical Device Company Pulmonx Files for IPO
DJ
02/27BOSTON SCIENTIFIC CORP : Entry into a Material Definitive Agreement, Creation of..
AQ
02/25BOSTON SCIENTIFIC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
AQ
02/24BOSTON SCIENTIFIC : Description Statement of Changes in Beneficial Ownership
PU
02/18BOSTON SCIENTIFIC : Description Initial Statement of Beneficial Ownership
PU
02/18BOSTON SCIENTIFIC : Description Statement of Changes in Beneficial Ownership
PU
02/18BOSTON SCIENTIFIC : Announces February and March 2020 Conference Schedule
PR
02/14BOSTON SCIENTIFIC : Description Annual Statement of Changes in Beneficial Owners..
PU
02/13BOSTON SCIENTIFIC : Description Statement of Changes in Beneficial Ownership
PU
02/11BOSTON SCIENTIFIC : Description Statement of Changes in Beneficial Ownership
PU
02/07BOSTON SCIENTIFIC : Description Amended Statement of Ownership
PU
More news
News in other languages on BOSTON SCIENTIFIC CORPORAT
02/05TAGESVORSCHAU : Termine am 5. Februar 2020
01/31BOSTON SCIENTIFIC CORPORATION : publication des résultats annuels
01/31BOSTON SCIENTIFIC CORPORATION : Veröffentlichung des Jahresergebnisses
01/14BOSTON SCIENTIFIC CORPORATION : les ventes du 4ème trimestre seront inférieures ..
2019Résumé des principales informations économiques du mardi 10 décembre 2019
More news
Chart BOSTON SCIENTIFIC CORPORAT
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | MarketScreener
Technical analysis trends BOSTON SCIENTIFIC CORPORAT
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Average target price 46,44  $
Last Close Price 30,61  $
Spread / Highest target 89,5%
Spread / Average Target 51,7%
Spread / Lowest Target -1,99%
EPS Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian T. Meredith Global Chief Medical Officer & Executive VP
Jodi Eddy Chief Information Officer & SVP
Sector and Competitors